Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization.

Dina Grohmann1, Valentina Corradi, Mira Elbasyouny

  • 1Institut für Molekulare Medizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.

Chembiochem : a European Journal of Chemical Biology
|March 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elucidating the interplay between intracellular manganese-iron-ratio and radiotolerance across all domains of life.

FEMS microbes·2026
Same author

CsmR controls both, motility and cell shape, in Haloferax volcanii.

PLoS genetics·2026
Same author

Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors.

International journal of molecular sciences·2026
Same author

Impact of changed c-di-AMP levels and hypoosmotic stress on the transcriptome of <i>Haloferax volcanii</i> and on RCK domain-containing proteins.

microLife·2025
Same author

Pan-modification profiling facilitates a cross-evolutionary dissection of the thermoregulated ribosomal epitranscriptome.

Cell·2025
Same author

Simulated early Earth geochemistry fuels a hydrogen-dependent primordial metabolism.

Nature ecology & evolution·2025
Same journal

Reaction Optimization for Enzymatic Deconstruction of Industrially Relevant Nylon Composites.

Chembiochem : a European journal of chemical biology·2026
Same journal

Deploying Artificial Metalloenzymes in Complex Environments: Strategies and Applications.

Chembiochem : a European journal of chemical biology·2026
Same journal

Synthetic Ligands of Myeloid C-Type Lectin Receptors.

Chembiochem : a European journal of chemical biology·2026
Same journal

Vancomycin-Mediated Binding of DNA Origami Nanostructures to Gram-Positive and Gram-Negative Bacteria.

Chembiochem : a European journal of chemical biology·2026
Same journal

Mutasynthesis and Antibiotic Activity of Mupirocin Analogues.

Chembiochem : a European journal of chemical biology·2026
Same journal

Pressure-Dependent Aromatic Ring Flips Reveal Variable Transition-State Volume and Compressibility Among Structural Regions of BPTI.

Chembiochem : a European journal of chemical biology·2026
See all related articles

Researchers identified a novel small molecule inhibitor that disrupts human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) dimerization. This compound effectively inhibits both polymerase and RNase H activities, offering a new therapeutic avenue.

Area of Science:

  • Virology
  • Structural Biology
  • Drug Discovery

Background:

  • Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) enzymatic activity is dependent on its dimeric structure.
  • Inhibiting RT dimerization is a potential antiviral strategy against HIV-1.
  • The large subunit connection subdomain is crucial for RT subunit interaction.

Purpose of the Study:

  • To identify small molecules that inhibit HIV-1 RT dimerization using a structure-based ligand design approach.
  • To develop novel therapeutic agents targeting HIV-1 replication.

Main Methods:

  • Structure-based ligand design and pharmacophoric modeling of the RT large subunit connection subdomain.
  • Virtual screening of the ASINEX database for potential RT dimerization inhibitors.

Related Experiment Videos

  • In vitro subunit association assays to test identified compounds.
  • Enzymatic assays to evaluate inhibition of polymerase and RNase H activities.

    • Main Results:

    • A novel small molecule, MAS0, was identified that significantly reduces the association of HIV-1 RT subunits (p51 and p66).
    • MAS0 demonstrated dual inhibition of both polymerase and RNase H activities.
    • A slow isomerization step with a half-life of approximately 2 hours was observed, suggesting a shift to an inactive conformation.

    Conclusions:

    • This study presents the first successful rational screen for a small molecule HIV-1 RT dimerization inhibitor.
    • MAS0 represents a promising hit compound for developing new anti-HIV-1 therapeutic agents.
    • Targeting RT dimerization offers a viable strategy for novel antiviral drug development.